Cargando…
SNHG12: An LncRNA as a Potential Therapeutic Target and Biomarker for Human Cancer
Limitations in current diagnostic procedures warrant identification of new methodologies to improve diagnoses of cancer patients. In this context, long non-coding RNAs (lncRNAs) have emerged as stable biomarkers which are expressed abundantly in tumors. Importantly, these can be detected at all stag...
Autores principales: | Tamang, Suraksha, Acharya, Varnali, Roy, Deepronil, Sharma, Rinka, Aryaa, Apeksha, Sharma, Uttam, Khandelwal, Akanksha, Prakash, Hridayesh, Vasquez, Karen M., Jain, Aklank |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6759952/ https://www.ncbi.nlm.nih.gov/pubmed/31620362 http://dx.doi.org/10.3389/fonc.2019.00901 |
Ejemplares similares
-
Cancer Susceptibility Candidate 9 (CASC9): A Novel Targetable Long Noncoding RNA in Cancer Treatment
por: Sharma, Uttam, et al.
Publicado: (2020) -
Long Non-Coding RNAs as Strategic Molecules to Augment the Radiation Therapy in Esophageal Squamous Cell Carcinoma
por: Sharma, Uttam, et al.
Publicado: (2020) -
Macrophage Activation Syndrome and COVID 19: Impact of MAPK Driven Immune-Epigenetic Programming by SARS-Cov-2
por: Roy, Roshan Kumar, et al.
Publicado: (2021) -
Circulating microRNA‐590‐5p functions as a liquid biopsy marker in non‐small cell lung cancer
por: Khandelwal, Akanksha, et al.
Publicado: (2020) -
The regulatory roles of long non-coding RNAs in the development of chemoresistance in breast cancer
por: Malhotra, Akshay, et al.
Publicado: (2017)